Occudo Quantitative Strategies LP Fulgent Genetics, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$19.09 - $22.57 $86,630 - $102,422	-4,538 Reduced 28.41%	11,437 $224,000
Q1 2024 May 15, 2024	SELL	$21.55 - $29.29 $231,985 - $315,306	-10,765 Reduced 40.26%	15,975 $346,000
Q4 2023 Feb 14, 2024	BUY	$23.64 - $30.27 $632,133 - $809,419	26,740 New	26,740 $773,000
Q2 2023 Aug 14, 2023	BUY	$28.52 - $40.7 $366,824 - $523,483	12,862 Added 111.48%	24,400 $903,000
Q1 2023 May 15, 2023	BUY	$29.39 - $36.27 $134,870 - $166,443	4,589 Added 66.04%	11,538 $360,000
Q4 2022 Feb 14, 2023	BUY	$29.23 - $40.28 $203,119 - $279,905	6,949 New	6,949 $206,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.